Research Projects

INTEGRIS Grove General was selected to be part of the TIMI-19 Study because of its excellent Emergency Medical Services and Emergency Room staff.  This meant that the Grove EMS would not only have an up-to-date communication system, it would also be one of the first emergency medical services in the country  to use thrombolytics (anti-clot medicine used to treat heart attack victims) as part of their advanced life-support pre-hospital care. Only 12 facilities in the U.S. were  selected to participate in the TIMI-19 study, and INTEGRIS Grove and Grove EMS together were one of the 12.

TIMI stands for "Thrombolysis in Myocardial Infarction" (heart attack). The 19 indicates that this was the 19th study in the use of clot-dissolving drugs in the treatment  of heart attacks. The drug used in this study, Retavase, saves an additional ten lives per thousand suffering heart attacks if the drug is administered in a timely  manner to eligible heart attack victims.

    Send Page to a Friend | Print Page | Add Page to Favorites
Site Index | Privacy Policy | Disclaimer | Release of Information | Contact Us

All health care services are provided through affiliates and/or
subsidiaries of INTEGRIS Health, Inc.


November 09
What's a Pain Management Doctor?
Culinary Delights-Baking with Agave Nectar
Intermediate Computer (4 day) TAL
November 10
Red, Orange, Green...Colorful Holiday Side Dishes
INTEGRIS Surgical Weight Loss Seminar
November 11
Healthy Heart Walkers Spanish Club
more...
Visit our Web Nursery
 
 
INTEGRIS Grove General Hospital
1310 S. Main
Grove, OK 74344
(918) 786-2243

INTEGRIS HealthLine
(888) 951-2277